EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP‐P Analysis

Cyrus W Abrahamson iD, Thomas Q McClelland iD, David J Fei-Zhang iD, Jill N D'Souza iD, Anthony M Sheyn iD, Jeffrey C Rastatter iD, Daniel C Chelius iD

Otolaryngology–Head and Neck Surgery · 2026-05 · 174 (5) · 1243-1252

DOI: 10.1002/ohn.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 03.03.2026. Verfasst von Cyrus W Abrahamson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Thyroglossal Cyst, Antibiotic Prophylaxis, Branchioma, Surgical Wound Infection. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify patterns in prophylactic intravenous antibiotics (PIAB) usage for thyroglossal duct and branchial cleft cyst excisions, and to evaluate whether PIAB improve patient outcomes. Study Design Retrospective cohort study.

Setting

American College of Surgeons National Surgical Quality Improvement Program‐Pediatric (NSQIP‐P) Surgical Antibiotic Prophylaxis Database.

Methods

The NSQIP‐P database was queried for pediatric patients (≤18) from 2021 to 2023 who underwent thyroglossal duct or branchial cleft cyst excision. Multivariate regressions assessed associations between PIAB use and outcomes including surgical site infection, unplanned readmission, and reoperation while adjusting for clinicodemographic factors (age, sex, race/ethnicity, admission status, surgical specialty, ASA classification, and wound classification).

Results

Of 2106 TGDC and 2837 BCC patients, 83.5% and 68.0% received PIAB, respectively. Hispanic ethnicity, postoperative admission, and clean‐contaminated wound classification were associated with increased PIAB use in both groups. In BCC patients, younger age and treatment by non‐otolaryngologists predicted decreased PIAB use. While univariate analysis in TGDC cases showed lower infection rates with PIAB (OR, 0.52; 95% CI, 0.30‐0.95; P = .025), this was not significant on multivariate analysis (0.59, 0.34‐1.08, P = .074). PIAB did not significantly affect infection, readmission, or reoperation rates in either cohort on multivariate analysis.

Conclusion

PIAB use in pediatric TGDC and BCC excisions varies with clinicodemographic factors but did not consistently reduce adverse outcomes. These findings underscore the need to reevaluate the necessity of PIAB and encourage further investigations to develop evidence‐based guidelines for pediatric neck mass surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroglossal CystAntibiotic ProphylaxisBranchiomaSurgical Wound InfectionAnti-Bacterial AgentsHumansRetrospective StudiesFemaleChildMaleChild, PreschoolAdolescentInfantDatabases, FactualAdministration, Intravenous

Stichwörter der Autor:innen

branchial cleft cystpediatric otolaryngologysurgical antibiotic prophylaxisthyroglossal duct cyst

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Otolaryngology, Division of Pediatric Otolaryngology Children's Hospital of New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Department of Pediatric Otolaryngology, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
  • Division of Pediatric Otolaryngology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Cyrus W Abrahamson, Thomas Q McClelland, David J Fei-Zhang, Jill N D'Souza, Anthony M Sheyn, Jeffrey C Rastatter, Daniel C Chelius

Zitieren

APA

Abrahamson, C. W., McClelland, T. Q., Fei-Zhang, D. J., D'Souza, J. N., Sheyn, A. M., Rastatter, J. C., & Chelius, D. C. (2026). Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP‐P Analysis. Otolaryngology–Head and Neck Surgery, 174(5), 1243-1252. https://doi.org/10.1002/ohn.70186

Vancouver

Abrahamson CW, McClelland TQ, Fei-Zhang DJ, D'Souza JN, Sheyn AM, Rastatter JC, et al. Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP‐P Analysis. Otolaryngology–Head and Neck Surgery. 2026;174(5):1243-1252. doi:10.1002/ohn.70186

BibTeX
@article{Abrahamson2026,
  author = {Abrahamson, Cyrus W and McClelland, Thomas Q and Fei-Zhang, David J and D'Souza, Jill N and Sheyn, Anthony M and Rastatter, Jeffrey C and Chelius, Daniel C},
  title = {Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP‐P Analysis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  volume = {174},
  number = {5},
  pages = {1243--1252},
  doi = {10.1002/ohn.70186}
}
Kostenlos starten →